These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23422875)

  • 1. Effects of milnacipran on cognitive flexibility following chronic stress in rats.
    Naegeli KJ; O'Connor JA; Banerjee P; Morilak DA
    Eur J Pharmacol; 2013 Mar; 703(1-3):62-6. PubMed ID: 23422875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of desipramine on cognitive function of chronically stressed rats are mediated by alpha1-adrenergic receptors in medial prefrontal cortex.
    Bondi CO; Jett JD; Morilak DA
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):913-23. PubMed ID: 20417676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment.
    Bondi CO; Rodriguez G; Gould GG; Frazer A; Morilak DA
    Neuropsychopharmacology; 2008 Jan; 33(2):320-31. PubMed ID: 17406647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In the rat forced swimming test, chronic but not subacute administration of dual 5-HT/NA antidepressant treatments may produce greater effects than selective drugs.
    Rénéric JP; Bouvard M; Stinus L
    Behav Brain Res; 2002 Nov; 136(2):521-32. PubMed ID: 12429415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Too much of a good thing: blocking noradrenergic facilitation in medial prefrontal cortex prevents the detrimental effects of chronic stress on cognition.
    Jett JD; Morilak DA
    Neuropsychopharmacology; 2013 Mar; 38(4):585-95. PubMed ID: 23132268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic treatment with desipramine improves cognitive performance of rats in an attentional set-shifting test.
    Lapiz MD; Bondi CO; Morilak DA
    Neuropsychopharmacology; 2007 May; 32(5):1000-10. PubMed ID: 17077810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficits in cognitive flexibility induced by chronic unpredictable stress are associated with impaired glutamate neurotransmission in the rat medial prefrontal cortex.
    Jett JD; Bulin SE; Hatherall LC; McCartney CM; Morilak DA
    Neuroscience; 2017 Mar; 346():284-297. PubMed ID: 28131625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.
    Welsch P; Üçeyler N; Klose P; Walitt B; Häuser W
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD010292. PubMed ID: 29489029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats.
    Mochizuki D; Tsujita R; Yamada S; Kawasaki K; Otsuka Y; Hashimoto S; Hattori T; Kitamura Y; Miki N
    Psychopharmacology (Berl); 2002 Jul; 162(3):323-32. PubMed ID: 12122491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cognitive deficit induced in rats by chronic intermittent cold stress is reversed by chronic antidepressant treatment.
    Danet M; Lapiz-Bluhm S; Morilak DA
    Int J Neuropsychopharmacol; 2010 Sep; 13(8):997-1009. PubMed ID: 20149267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effects of milnacipran (serotonin noradrenalin reuptake inhibitor) on depression following mild and moderate traumatic brain injury.
    Kanetani K; Kimura M; Endo S
    J Nippon Med Sch; 2003 Aug; 70(4):313-20. PubMed ID: 12928711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical potential of milnacipran, a serotonin and norepinephrine reuptake inhibitor, in pain.
    Leo RJ; Brooks VL
    Curr Opin Investig Drugs; 2006 Jul; 7(7):637-42. PubMed ID: 16869117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Milnacipran for fibromyalgia: a useful addition to the treatment armamentarium.
    Bernstein CD; Albrecht KL; Marcus DA
    Expert Opin Pharmacother; 2013 May; 14(7):905-16. PubMed ID: 23506481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic intermittent cold stress and serotonin depletion induce deficits of reversal learning in an attentional set-shifting test in rats.
    Lapiz-Bluhm MD; Soto-Piña AE; Hensler JG; Morilak DA
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):329-41. PubMed ID: 18587666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remarkable effect of milnacipran, a serotonin-noradrenalin reuptake inhibitor (SNRI), on depressive symptoms in patients with Parkinson's disease who have insufficient response to selective serotonin reuptake inhibitors (SSRIs): two case reports.
    Takahashi H; Kamata M; Yoshida K; Higuchi H; Shimizu T
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):351-3. PubMed ID: 15694247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-lasting cognitive deficit induced by stress is alleviated by acute administration of antidepressants.
    Nikiforuk A; Popik P
    Psychoneuroendocrinology; 2011 Jan; 36(1):28-39. PubMed ID: 20580164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome.
    Häuser W; Urrútia G; Tort S; Uçeyler N; Walitt B
    Cochrane Database Syst Rev; 2013 Jan; (1):CD010292. PubMed ID: 23440848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Milnacipran and selective serotonin reuptake inhibitors in major depression.
    Lopez-Ibor J; Guelfi JD; Pletan Y; Tournoux A; Prost JF
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():41-6. PubMed ID: 8923126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The monoamine-mediated antiallodynic effects of intrathecally administered milnacipran, a serotonin noradrenaline reuptake inhibitor, in a rat model of neuropathic pain.
    Obata H; Saito S; Koizuka S; Nishikawa K; Goto F
    Anesth Analg; 2005 May; 100(5):1406-1410. PubMed ID: 15845695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Milnacipran Treatment on Ventricular Lactate in Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Natelson BH; Vu D; Mao X; Weiduschat N; Togo F; Lange G; Blate M; Kang G; Coplan JD; Shungu DC
    J Pain; 2015 Nov; 16(11):1211-9. PubMed ID: 26335989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.